Calcican Nasal Spray 3.7ml is a prescription medication containing calcitonin, a hormone that helps regulate calcium levels and bone metabolism. This nasal spray formulation delivers synthetic salmon calcitonin through the nasal mucosa, offering a convenient alternative to injectable preparations. Calcican is commonly used to treat postmenopausal osteoporosis, Paget’s disease of bone and hypercalcemia, conditions characterized by excessive bone resorption or high calcium levels. By inhibiting the activity of osteoclasts – the cells responsible for breaking down bone tissue – calcitonin slows bone turnover, helps maintain bone density and reduces the risk of fractures.
Each 3.7ml bottle contains multiple doses, typically administered once daily in one nostril, alternating nostrils each day to minimize local irritation. Patients should prime the pump before the first use and gently clear their nostrils prior to spraying. It is important to hold the head upright, insert the nozzle into the nostril and press the pump firmly while breathing in gently. After spraying, the nozzle should be rinsed and dried. Patients should follow the dosing instructions provided by their healthcare provider and not exceed the recommended dose.
Common side effects of Calcican Nasal Spray may include nasal irritation, dryness, redness, sneezing or a runny nose. Some individuals may experience headaches, dizziness or nausea. Because calcitonin is a hormone, allergic reactions are possible; patients should discontinue use and seek medical attention if they develop rash, hives or difficulty breathing. Long-term use of calcitonin may be associated with a slight increase in cancer risk; patients should discuss the benefits and risks with their healthcare provider. Calcican may not be suitable for individuals with severe nasal conditions or allergies to salmon products. Regular monitoring of bone density and calcium levels is recommended to assess treatment efficacy. When used under proper medical supervision, Calcican Nasal Spray 3.7ml provides an effective option for managing bone disorders and maintaining healthy calcium metabolism.
Each 3.7ml bottle contains multiple doses, typically administered once daily in one nostril, alternating nostrils each day to minimize local irritation. Patients should prime the pump before the first use and gently clear their nostrils prior to spraying. It is important to hold the head upright, insert the nozzle into the nostril and press the pump firmly while breathing in gently. After spraying, the nozzle should be rinsed and dried. Patients should follow the dosing instructions provided by their healthcare provider and not exceed the recommended dose.
Common side effects of Calcican Nasal Spray may include nasal irritation, dryness, redness, sneezing or a runny nose. Some individuals may experience headaches, dizziness or nausea. Because calcitonin is a hormone, allergic reactions are possible; patients should discontinue use and seek medical attention if they develop rash, hives or difficulty breathing. Long-term use of calcitonin may be associated with a slight increase in cancer risk; patients should discuss the benefits and risks with their healthcare provider. Calcican may not be suitable for individuals with severe nasal conditions or allergies to salmon products. Regular monitoring of bone density and calcium levels is recommended to assess treatment efficacy. When used under proper medical supervision, Calcican Nasal Spray 3.7ml provides an effective option for managing bone disorders and maintaining healthy calcium metabolism.
0